Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Chang, Hyo Won | - |
dc.contributor.author | Lee, Yoon Se | - |
dc.contributor.author | Nam, Hae Yun | - |
dc.contributor.author | Han, Myoung Wol | - |
dc.contributor.author | Kim, Hyo Jung | - |
dc.contributor.author | Moon, So Young | - |
dc.contributor.author | Jeon, Hyesung | - |
dc.contributor.author | Park, Jung Je | - |
dc.contributor.author | Carey, Thomas E. | - |
dc.contributor.author | Chang, Sung Eun | - |
dc.contributor.author | Kim, Seong Who | - |
dc.contributor.author | Kim, Sang Yoon | - |
dc.date.accessioned | 2024-01-20T12:33:18Z | - |
dc.date.available | 2024-01-20T12:33:18Z | - |
dc.date.created | 2021-09-05 | - |
dc.date.issued | 2013-04 | - |
dc.identifier.issn | 0898-6568 | - |
dc.identifier.uri | https://pubs.kist.re.kr/handle/201004/128191 | - |
dc.description.abstract | The Wnt/beta-catenin pathway regulates the viability and radiosensitivity of head and neck squamous cancer cells (HNSCC). Increased beta-catenin predisposes HNSCC patients to poor prognosis and survival. This study was conducted to determine the mechanism by which beta-catenin regulates the viability of HNSCC. AMC-HN-3, -HN-8, UM-SCC-38, and -SCC-47 cells, which were established from human head and neck cancer specimens, and underwent cell death following beta-catenin silencing. beta-Catenin silencing significantly induced G1 arrest and increased the expression of Bax and active caspase-3, which demonstrates the sequential activation of apoptotic cascades following treatment of HNSCC with targeted siRNA. Intriguingly, beta-catenin silencing also induced autophagy. Here, we confirm that the number of autophagic vacuoles and the expression of type II light chain 3 were increased in cells that were treated with beta-catenin siRNA. These cell death modes are most likely due to the activation of LKB1-dependent AMPK following beta-catenin silencing. The activated LKB1/AMPK pathway in AMC-HN-3 cells caused G1 arrest by phosphorylating p53 and suppressing mTOR signaling. In addition, treating AMC-HN-3 cells with LKB1 siRNA preserved cell viability against beta-catenin silencing-induced cytotoxicity. Taken together, these results imply that following beta-catenin silencing, HNSCC undergo both apoptotic and autophagic cell death that are under the control of LKB1/AMPK. To the best of our knowledge, these results suggest for the first time that novel crosstalk between beta-catenin and the LKB1/AMPK pathway regulates the viability of HNSCC. This study thus presents new insights into our understanding of the cellular and molecular mechanisms involved in beta-catenin silencing-induced cell death. (C) 2012 Elsevier Inc. All rights reserved. | - |
dc.language | English | - |
dc.publisher | ELSEVIER SCIENCE INC | - |
dc.subject | ACTIVATED PROTEIN-KINASE | - |
dc.subject | LKB1 TUMOR-SUPPRESSOR | - |
dc.subject | WNT | - |
dc.subject | PATHWAY | - |
dc.subject | GROWTH | - |
dc.subject | INHIBITION | - |
dc.subject | HYPOXIA | - |
dc.subject | EXPRESSION | - |
dc.subject | GSK-3-BETA | - |
dc.title | Knockdown of beta-catenin controls both apoptotic and autophagic cell death through LKB1/AMPK signaling in head and neck squamous cell carcinoma cell lines | - |
dc.type | Article | - |
dc.identifier.doi | 10.1016/j.cellsig.2012.12.020 | - |
dc.description.journalClass | 1 | - |
dc.identifier.bibliographicCitation | CELLULAR SIGNALLING, v.25, no.4, pp.839 - 847 | - |
dc.citation.title | CELLULAR SIGNALLING | - |
dc.citation.volume | 25 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 839 | - |
dc.citation.endPage | 847 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.identifier.wosid | 000317161700015 | - |
dc.identifier.scopusid | 2-s2.0-84873305194 | - |
dc.relation.journalWebOfScienceCategory | Cell Biology | - |
dc.relation.journalResearchArea | Cell Biology | - |
dc.type.docType | Article | - |
dc.subject.keywordPlus | ACTIVATED PROTEIN-KINASE | - |
dc.subject.keywordPlus | LKB1 TUMOR-SUPPRESSOR | - |
dc.subject.keywordPlus | WNT | - |
dc.subject.keywordPlus | PATHWAY | - |
dc.subject.keywordPlus | GROWTH | - |
dc.subject.keywordPlus | INHIBITION | - |
dc.subject.keywordPlus | HYPOXIA | - |
dc.subject.keywordPlus | EXPRESSION | - |
dc.subject.keywordPlus | GSK-3-BETA | - |
dc.subject.keywordAuthor | beta-catenin | - |
dc.subject.keywordAuthor | LKB1/AMPK | - |
dc.subject.keywordAuthor | Apoptosis | - |
dc.subject.keywordAuthor | Autophagy | - |
dc.subject.keywordAuthor | Head and neck neoplasm | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.